2025
SJR Q1
JCR Q1 · 6,6
OA
20 matched articles
SCIE
Journal detail
CNS Neuroscience and Therapeutics
- Publisher
- John Wiley and Sons Inc
- Country
- United Kingdom · Western Europe
- Type
- journal
- ISSN
-
1755593017555949
Integrated evaluation
Scopus side is Scimago SJR; WoS side is Master Journal List + JCR/JIF. Sources are matched on ISSN. WoS / JCR metrics are available for 1997 and later years only.
WoS / JCR data covers 1997 onward.
Scopus
Scopus · Scimago
- SJR 1,741
- Quartile Q1
- H-Index 105
- Cites/doc 6,46
- Docs (3y) 1.254
- Cites (3y) 8.240
Clarivate
Web of Science · JCR · 2025
- JCR Q Q1
- JIF 6,6
- 5Y JIF 6,9
- JCI 1,38
WoS indexes
- SCIE
Subject classification
Categories (SJR)
- Pharmacology Q1
- Pharmacology (medical) Q1
- Physiology (medical) Q1
- Psychiatry and Mental Health Q1
Areas
- Medicine
- Pharmacology, Toxicology and Pharmaceutics
WoS categories
- Neurosciences | Pharmacology & Pharmacy
Yearly quartile comparison
Scimago (SJR) for all years; Clarivate (JCR / JIF / JCI) from 1997 onward. Latest year stays open; older years start collapsed.
WoS / JCR data covers 1997 onward.
| Year | SJR Q | JCR Q (1997+) | SJR | JIF (1997+) | 5Y JIF (1997+) | JCI (1997+) | JCI Q (1997+) | H-Index |
|---|---|---|---|---|---|---|---|---|
| 2025 | Q1 | Q1 | 1,741 | 6,6 | 6,9 | 1,38 | Q1 | 105 |
| 2024 | Q1 | Q1 | 1,676 | 5 | 5,8 | 1,29 | Q1 | 99 |
| 2023 | Q1 | Q1 | 1,473 | 4,8 | 5,9 | 1,26 | Q1 | 99 |
| 2022 | Q1 | Q1 | 1,381 | 5,5 | 6,2 | 1,3 | Q1 | 99 |
| 2021 | Q1 | Q1 | 1,364 | 7 | 6,3 | 1,23 | Q1 | 99 |
| 2020 | Q1 | Q1 | 1,403 | 5,2 | 5 | 1,23 | Q1 | 99 |
| 2019 | Q1 | Q1 | 1,241 | 4,1 | 3,9 | 1,07 | Q1 | 99 |
| 2018 | — | Q2 | — | 3,4 | 3,7 | 1 | Q2 | — |
| 2017 | Q1 | Q1 | 1,38 | 3,5 | 4,1 | 1,06 | Q1 | 99 |
| 2016 | Q1 | Q1 | 1,567 | 3,9 | 4 | — | — | 99 |
| 2015 | Q1 | Q1 | 1,553 | 4 | 4,1 | — | — | 99 |
| 2014 | Q1 | Q1 | 1,619 | 3,9 | 4 | — | — | 99 |
| 2013 | Q1 | Q1 | 1,603 | 3,8 | 4,1 | — | — | 99 |
| 2012 | Q1 | Q1 | 1,604 | 4,5 | 4,4 | — | — | 99 |
| 2011 | Q1 | Q1 | 1,437 | 4,4 | 4,5 | — | — | 99 |
| 2010 | Q1 | Q1 | 1,013 | 3,5 | 3,5 | — | — | 99 |
| 2009 | — | Q2 | — | 2,7 | 2,7 | — | — | — |
| 2008 | — | — | — | — | — | — | — | — |
JCR category quartile history
JCR / JCI quartile by year and category. 1997 and later.
WoS / JCR data covers 1997 onward.
| Year | Category | Edition | JCR Q (1997+) | JCI Q (1997+) | Rank |
|---|---|---|---|---|---|
| 2025 | NEUROSCIENCES | SCIE | Q1 | Q1 | 44/330 |
| 2025 | PHARMACOLOGY & PHARMACY | SCIE | Q1 | Q1 | 40/356 |
| 2024 | NEUROSCIENCES | SCIE | Q1 | Q1 | 51/314 |
| 2024 | PHARMACOLOGY & PHARMACY | SCIE | Q1 | Q1 | 47/352 |
| 2023 | NEUROSCIENCES | SCIE | Q1 | Q1 | 57/310 |
| 2023 | PHARMACOLOGY & PHARMACY | SCIE | Q1 | Q1 | 50/354 |
| 2022 | NEUROSCIENCES | SCIE | Q1 | Q1 | 59/272 |
| 2022 | PHARMACOLOGY & PHARMACY | SCIE | Q1 | Q1 | 48/278 |
| 2021 | NEUROSCIENCES | SCIE | Q1 | Q1 | 44/275 |
| 2021 | PHARMACOLOGY & PHARMACY | SCIE | Q1 | Q1 | 31/279 |
| 2020 | NEUROSCIENCES | SCIE | Q2 | Q1 | 73/273 |
| 2020 | PHARMACOLOGY & PHARMACY | SCIE | Q1 | Q1 | 55/276 |
| 2019 | NEUROSCIENCES | SCIE | Q2 | Q2 | 84/272 |
| 2019 | PHARMACOLOGY & PHARMACY | SCIE | Q1 | Q1 | 59/271 |
| 2018 | NEUROSCIENCES | SCIE | Q2 | Q2 | 107/267 |
| 2018 | PHARMACOLOGY & PHARMACY | SCIE | Q2 | Q2 | 80/267 |
| 2017 | NEUROSCIENCES | SCIE | Q2 | Q2 | 92/261 |
| 2017 | PHARMACOLOGY & PHARMACY | SCIE | Q1 | Q1 | 65/261 |
| 2016 | NEUROSCIENCES | SCIE | Q2 | — | 70/259 |
| 2016 | PHARMACOLOGY & PHARMACY | SCIE | Q1 | — | 47/257 |
| 2015 | NEUROSCIENCES | SCIE | Q2 | — | 65/256 |
| 2015 | PHARMACOLOGY & PHARMACY | SCIE | Q1 | — | 43/255 |
| 2014 | NEUROSCIENCES | SCIE | Q2 | — | 68/252 |
| 2014 | PHARMACOLOGY & PHARMACY | SCIE | Q1 | — | 43/255 |
| 2013 | NEUROSCIENCES | SCIE | Q2 | — | 81/252 |
| 2013 | PHARMACOLOGY & PHARMACY | SCIE | Q1 | — | 46/256 |
| 2012 | NEUROSCIENCES | SCIE | Q1 | — | 55/252 |
| 2012 | PHARMACOLOGY & PHARMACY | SCIE | Q1 | — | 33/261 |
| 2011 | NEUROSCIENCES | SCIE | Q1 | — | 53/244 |
| 2011 | PHARMACOLOGY & PHARMACY | SCIE | Q1 | — | 33/261 |
| 2010 | NEUROSCIENCES | SCIE | Q2 | — | 84/239 |
| 2010 | PHARMACOLOGY & PHARMACY | SCIE | Q1 | — | 62/252 |
| 2009 | NEUROSCIENCES | SCIE | Q3 | — | 122/231 |
| 2009 | PHARMACOLOGY & PHARMACY | SCIE | Q2 | — | 94/237 |
| 2008 | NEUROSCIENCES | SCIE | — | — | — |
| 2008 | PHARMACOLOGY & PHARMACY | SCIE | — | — | — |